◆ 会议时间：2025年2月5-8日
◆ 会议地点：美国 丹佛

◆ 会议简介：

2025年美国临终关怀与姑息治疗年度会议将于2025年2月5-8日在美国丹佛举行，会议由美国临终关怀与姑息医学协会(AAHPM)与临终关怀与姑息护士学会(HPNA)联合组织，预计有3400余名代表出席会议。 临终关怀与姑息治疗年会是专为医师、护士、高级执业注册护士、药剂师、医师助理、社会工作者和牧师设计的，他们可以获得、维持或扩展在临终关怀和姑息治疗领域宣高效运行所需的技能。每年一次的临终关怀与姑息护理大会将利用AAHPM和HPNA的专业知识来促进这一领域的发展，为其成员和其他相关专业人士提供教育，并通过分享现有的最佳证据来提高重症患者的生活质量。

美国临终关怀与姑息医学协会(AAHPM)成立于1988年，是专门为从事临终关怀与姑息医学的医师、护士和其他医疗服务提供者而创建的专业组织，现拥有超过5200名成员。AAHPM致力于促进临终关怀与姑息医学的发展，不断改善对重症患者的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

The Annual Assembly of Hospice and Palliative Care

Date: February 5-8, 2025
Venue: Denver Convention Center, Denver, CO, USA

The Annual Assembly of Hospice and Palliative Care, presented by the American Academy of Hospice and Palliative Medicine (AAHPM) and the Hospice and Palliative Nurses Association (HPNA), is a 3-day event that brings together more than 3,400 of your colleagues and peers to share research, clinical best practices, and practice-related guidance to advance the specialty and improve patient care.  

摘要征文投稿：

Principal Call for Abstracts on Emerging Scientific and Clinical Advances in the Field of Hospice and Palliative Care

This call is now open through August 12.

Abstracts submitted through the Principal Call for Abstracts are for the Annual Assembly of Hospice and Palliative Care which will take place February 5-8, 2025, in Denver, CO.

The Annual Assembly will be presented as a modified hybrid event with combined live streaming and in-person experiences, and on-demand access through May 2025.

About the Call

The principal call is open to all hospice and palliative care professionals across all settings and career stages including early career and professionals in training. Selected content is intended to enrich hospice and palliative care, education, science, and practice.

All scientific research referred to, reported, or used in this accredited educational conference in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation.

The Annual Assembly Co-Chairs and Planning Committee will determine the final presentation length based on the submitter’s requested preferred length, submission review, scoring, selection, and acceptance.

The Principal Call for Abstracts will close on August 12 at 11:59pm PT.

Abstract Submission Options

• 60-minute Podium Presentations (up to 23 abstracts will be accepted)
• 25-minute Podium Presentations (up to 48 abstracts will be accepted)
• 15-minute Podium Presentations (up to 32 abstracts will be accepted)
• Poster Presentations (up to 100 abstracts will be accepted)

Important Primary and Contributing Author(s) Information

• The max number of abstracts allowed per primary submitter is three (3).
• Primary (first) author’s full first and last name, credentials, and current institutional affiliation, city and state.
  • Please note: Names and credentials will be published as submitted.
• Disclosures: relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients are to be disclosed at the time of abstract submission for the primary and contributing authors.
• Applicable disclosure mitigation will be completed at the time of abstract selection prior to selection for acceptance.
  

Submit an Abstract

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。